LILIAN MIKAEL
Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine CONCORD, MA NPI 1245346162
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine MA GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$5,421.59
- Category: General Payments
- Program years: PY2018–2024
- Record count: 98
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $684.11 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $684.11 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $130.04 | 1 |
| Phathom Pharmaceuticals, Inc. | $120.55 | 1 |
| Neurocrine BioSciences, Inc. | $119.38 | 1 |
| Acerta Pharma LLC | $118.95 | 1 |
| Biogen, Inc. | $93.13 | 1 |
| ORGANOGENESIS INC. | $73.66 | 1 |
| PFIZER INC. | $28.40 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104872880 | Biogen, Inc. | $93.13 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105589912 | AstraZeneca Pharmaceuticals LP | $118.95 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116631132 | GlaxoSmithKline, LLC. | $130.04 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131946980 | PFIZER INC. | $28.40 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145439065 | Organogenesis Inc. | $73.66 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150810526 | Neurocrine Biosciences, Inc. | $119.38 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151096915 | Phathom Pharmaceuticals, Inc. | $120.55 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.